NAM
KDNY

Nexpoint Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Nexpoint Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-282,592
Closed -$10.9M – 112
2023
Q2 		$10.9M Buy
+282,592
New +$10.9M 1.58% 14